Yoshihiro Hatta

Yoshihiro Hatta

Nihon University

H-index: 32

Asia-Japan

About Yoshihiro Hatta

Yoshihiro Hatta, With an exceptional h-index of 32 and a recent h-index of 18 (since 2020), a distinguished researcher at Nihon University, specializes in the field of hematology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Space disinfection using TiO2 photocatalyst reduces the incidence of febrile neutropenia in cancer patients

Utility of allogeneic stem cell transplantation for adult Ph+ ALL with complete molecular remission

Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double …

Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi …

Differential clinical impact of letermovir prophylaxis according to graft sources: a KSGCT multicenter retrospective analysis

Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice

Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience

Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study

Yoshihiro Hatta Information

University

Position

professor of medicine School of Medicine

Citations(all)

4021

Citations(since 2020)

1103

Cited By

3322

hIndex(all)

32

hIndex(since 2020)

18

i10Index(all)

89

i10Index(since 2020)

35

Email

University Profile Page

Nihon University

Google Scholar

View Google Scholar Profile

Yoshihiro Hatta Skills & Research Interests

hematology

Top articles of Yoshihiro Hatta

Title

Journal

Author(s)

Publication Date

Space disinfection using TiO2 photocatalyst reduces the incidence of febrile neutropenia in cancer patients

Kazuihde Iizuka

Heihachiro Ochiai

Toyohiro Harazono

Yoshikazu Iizuka

Sachio Tsuchida

...

2024/2/15

Utility of allogeneic stem cell transplantation for adult Ph+ ALL with complete molecular remission

American Journal of Hematology

Satoshi Nishiwaki

Isamu Sugiura

Shin Fujisawa

Yoshihiro Hatta

Yoshiko Atsuta

...

2024/2/5

Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double …

Masataka Kuwana

Tomoki Ito

Shugo Kowata

Yoshihiro Hatta

Katsumichi Fujimaki

...

2024/2

Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi …

International Journal of Hematology

Noriyoshi Iriyama

Eisaku Iwanaga

Yuta Kimura

Naoki Watanabe

Maho Ishikawa

...

2024/4/8

Differential clinical impact of letermovir prophylaxis according to graft sources: a KSGCT multicenter retrospective analysis

Blood Advances

Takashi Toya

Kota Mizuno

Masatoshi Sakurai

Jun Kato

Takehiko Mori

...

2024/3/12

Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice

Internal Medicine

Shun Tsuchiya

Tomoiku Takaku

Naoki Watanabe

Noriyoshi Iriyama

Yuta Kimura

...

2023/11/15

Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience

Leukemia & Lymphoma

Noriyoshi Iriyama

Katsuhiro Miura

Hiromichi Takahashi

Masaru Nakagawa

Kazuhide Iizuka

...

2023/1/2

Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study

International Journal of Hematology

Chikashi Yoshida

Hiroki Yamaguchi

Noriko Doki

Kazunori Murai

Masaki Iino

...

2023/5

Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation

Shun-ichi Kimura

Hiroaki Shimizu

Takuya Miyazaki

Masatoshi Sakurai

Susumu Tanoue

...

2023/4

PB2301: OPTIMAL DOSE INTENSITY OF R-CHOP FOR PATIENTS WITH DLBCL AGED 80 YEARS OR OLDER: IS THE R-MINICHOP A GOLD STANDARD?

HemaSphere

Hironao Nukariya

Katsuhiro Miura

Hiromichi Takahashi

Masaru Nakagawa

Takashi Hamada

...

2023/8/1

Thrombotic microangiopathy with gastrointestinal hemorrhage during carfilzomib therapy for multiple myeloma

[Rinsho Ketsueki] The Japanese Journal of Clinical Hematology

Shuhei Matsumoto

Hiromichi Takahashi

Takashi Hamada

Katsuhiro Miura

Masaru Nakagwa

...

2023/1/1

Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and …

International Journal of Hematology

Michihide Tokuhira

Yuta Kimura

Takayuki Tabayashi

Naoki Watanabe

Shun Tsuchiya

...

2023/8

Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation

Case Reports in Oncology

Takashi Hamada

Hiromichi Takahashi

Masaru Nakagawa

Hironao Nukariya

Shun Ito

...

2023/3/7

Macrophage depletion using clodronate liposomes reveals latent dysfunction of the hematopoietic microenvironment associated with persistently imbalanced M1/M2 macrophage …

Annals of Hematology

Takashi Koike

Katsuhiro Miura

Yoshihiro Hatta

Hideki Nakamura

Yoko Hirabayashi

...

2023/12

High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph+ ALL TKI-SCT Study

HemaSphere

Satoshi Nishiwaki

Isamu Sugiura

Shin Fujisawa

Yoshihiro Hatta

Yoshiko Atsuta

...

2023/6/1

Measuring CD8-Positive T-Cells in the Tumor Microenvironment in Classical Hodgkin Lymphoma Using Multiplex Immunofluorescence Staining and Image Analysis: A Possible Prognostic …

Blood

Hiromichi Takahashi

Shun Ito

Yoko Nakanishi

Katsuhiro Miura

Masaru Nakagawa

...

2023/11/28

Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo‐controlled, double‐blind, parallel‐group study

British Journal of Haematology

Masataka Kuwana

Tomoki Ito

Shugo Kowata

Yoshihiro Hatta

Katsumichi Fujimaki

...

2023/3

Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a …

The Lancet Haematology

Atsushi Sato

Yoshihiro Hatta

Chihaya Imai

Koichi Oshima

Yasuhiro Okamoto

...

2023/6/1

Real-World Data in a Prospective Clinical Observation Study for Newly Diagnosed Adult Acute Lymphoblastic Leukemia, the JALSG ALL-CS-12: Advanced Age Is a Poor Prognostic Factor

Blood

Yoshihiro Hatta

Fumihiko Hayakawa

Etsuko Yamazaki

Tohru Murayama

Takeshi Saito

...

2023/11/28

Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience

Journal of pharmaceutical health care and sciences

Shinya Tsuboi

Tatsuya Hayama

Katsuhiro Miura

Akihiro Uchiike

Daisuke Tsutsumi

...

2023/1/10

See List of Professors in Yoshihiro Hatta University(Nihon University)